Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade - Comparison of transradial vs transfemoral arterial access
Autore:
Choussat, R; Black, A; Bossi, I; Fajadet, J; Marco, J;
Indirizzi:
Clin Pasteur, Unite Cardiol Interventionelle, F-31076 Toulouse, France Clin Pasteur Toulouse France F-31076 ntionelle, F-31076 Toulouse, France Geelong Hosp, Dept Cardiol, Geelong, Vic, Australia Geelong Hosp Geelong Vic Australia Dept Cardiol, Geelong, Vic, Australia
Titolo Testata:
EUROPEAN HEART JOURNAL
fascicolo: 8, volume: 21, anno: 2000,
pagine: 662 - 667
SICI:
0195-668X(200004)21:8<662:VCACOA>2.0.ZU;2-V
Fonte:
ISI
Lingua:
ENG
Soggetto:
STENT IMPLANTATION;
Keywords:
coronary angioplasty; transradial; complications;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
22
Recensione:
Indirizzi per estratti:
Indirizzo: Choussat, R Clin Pasteur, Unite Cardiol Interventionelle, 45 Ave Lombez, F-31076 Toulouse, France Clin Pasteur 45 Ave Lombez Toulouse France F-31076se, France
Citazione:
R. Choussat et al., "Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade - Comparison of transradial vs transfemoral arterial access", EUR HEART J, 21(8), 2000, pp. 662-667

Abstract

Aims Vascular complications associated with femoral artery access for interventional cardiological procedures may increase morbidity especially in patients receiving anticoagulants, aspirin, ticlopidine and platelet glycoprotein IIb/IIIa receptor inhibitors. The use of radial arterial access has the potential to reduce the incidence of access site bleeding complications. The purpose of this study was to compare outcomes after the radial and femoral approaches in patients treated with the platelet IIb/IIIa inhibitor, abciximab. Methods and Results One hundred and fifty consecutive patients treated by abciximab underwent angioplasty by the radial or femoral approach in 83 and67 cases, respectively. Outcome variables were major cardiac events and major access site bleeding at 1-month follow-up. Freedom from major cardiac events at 1-month follow-up occurred in 78 (93.9%) and 63 (94.0%) patients in the radial and femoral groups, respectively (P=0.99). There were no majoraccess site bleeding complications in the radial group, as opposed to five(7.4%) in the femoral group, r=0.04. Postprocedure length of stay, days (3.7 +/- 6.0 radial vs 3.7 +/- 2.6 femoral, P=0.96) as well as total hospitallength of stay (5.0 +/- 3.3 radial vs 4.9 +/- 3.0 femoral, P=0.72) were similar in both groups. Conclusion Coronary angioplasty in patients treated by abciximab using thetransradial approach is efficacious with fewer major access site complications than with the transfemoral approach. (Eur Heart J 2000; 21: 662-667) (C) 2000 The European Society of Cardiology.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/03/20 alle ore 22:58:48